Gennecs is setting up the biggest state-of-the-art vaccine facility across the emerging markets.
Having all the manufacturing phases including R&D, Seeds formulation, BSL-3 Labs / Cabinets complying with the WHO PQ and the European GMP.
Gennecs is committed to the highest manufacturing quality by bridging the gap between local demand and global supply.
Our portfolio is comprised of a wide range of nomenclature, including the production of under- licensed original products, pharmaceutical generics, modified generics/super generics, full portfolio for vaccines, food supplements, as well as various medical devices & laboratory equipment.
In addition, our company is the regional distribution and agency holder for multiple biotech products.
Driven by the passion to have more access to treatment across the emerging markets through building a state-of-the-art facility in Egypt to close the gap all over Africa with consistent supply and full control from Africans to Africans.
Dedicated to establish world-class partnerships and commercialize the products for the international markets, emerging markets, Africa & the MEA region; we are also active around the globe with partnerships in USA, Canada, India, China, Vietnam, Germany, and Korea.
Dedicated to establish world-class partnerships and commercialize the products for the international markets, emerging markets, Africa & the MENA region; we are also active around the globe with partnerships in USA, Canada, India, China, Vietnam, Germany, and Korea.
